These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 31703822)

  • 1. Role of myeloid cells in the immunosuppressive microenvironment in gliomas.
    Locarno CV; Simonelli M; Carenza C; Capucetti A; Stanzani E; Lorenzi E; Persico P; Della Bella S; Passoni L; Mavilio D; Bonecchi R; Locati M; Savino B
    Immunobiology; 2020 Jan; 225(1):151853. PubMed ID: 31703822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
    Roesch S; Rapp C; Dettling S; Herold-Mende C
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Myeloid Cells in GBM Immunosuppression.
    Lin YJ; Wu CY; Wu JY; Lim M
    Front Immunol; 2022; 13():887781. PubMed ID: 35711434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cells.
    Hasan MN; Luo L; Ding D; Song S; Bhuiyan MIH; Liu R; Foley LM; Guan X; Kohanbash G; Hitchens TK; Castro MG; Zhang Z; Sun D
    Theranostics; 2021; 11(3):1295-1309. PubMed ID: 33391535
    [No Abstract]   [Full Text] [Related]  

  • 5. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives.
    Lin H; Liu C; Hu A; Zhang D; Yang H; Mao Y
    J Hematol Oncol; 2024 May; 17(1):31. PubMed ID: 38720342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune microenvironment of gliomas.
    Gieryng A; Pszczolkowska D; Walentynowicz KA; Rajan WD; Kaminska B
    Lab Invest; 2017 May; 97(5):498-518. PubMed ID: 28287634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs.
    Lakshmanachetty S; Cruz-Cruz J; Hoffmeyer E; Cole AP; Mitra SS
    Cells; 2021 Apr; 10(4):. PubMed ID: 33919732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells.
    Chang AL; Miska J; Wainwright DA; Dey M; Rivetta CV; Yu D; Kanojia D; Pituch KC; Qiao J; Pytel P; Han Y; Wu M; Zhang L; Horbinski CM; Ahmed AU; Lesniak MS
    Cancer Res; 2016 Oct; 76(19):5671-5682. PubMed ID: 27530322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microglia/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology.
    Gutmann DH; Kettenmann H
    Neuron; 2019 Nov; 104(3):442-449. PubMed ID: 31697921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The controversial role of microglia in malignant gliomas.
    Wei J; Gabrusiewicz K; Heimberger A
    Clin Dev Immunol; 2013; 2013():285246. PubMed ID: 23983766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism and therapeutic potential of tumor-immune symbiosis in glioblastoma.
    Pang L; Khan F; Heimberger AB; Chen P
    Trends Cancer; 2022 Oct; 8(10):839-854. PubMed ID: 35624002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma-associated microglia/macrophages (GAMs) in glioblastoma: Immune function in the tumor microenvironment and implications for immunotherapy.
    Lin C; Wang N; Xu C
    Front Immunol; 2023; 14():1123853. PubMed ID: 36969167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The immunosuppressive microenvironment of malignant gliomas].
    Borisov KE; Sakaeva DD
    Arkh Patol; 2015; 77(6):54-63. PubMed ID: 26841651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of intimate and long-distance cross-talk between glioma and myeloid cells: how to break a vicious cycle.
    Wurdinger T; Deumelandt K; van der Vliet HJ; Wesseling P; de Gruijl TD
    Biochim Biophys Acta; 2014 Dec; 1846(2):560-75. PubMed ID: 25453365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
    Kamran N; Kadiyala P; Saxena M; Candolfi M; Li Y; Moreno-Ayala MA; Raja N; Shah D; Lowenstein PR; Castro MG
    Mol Ther; 2017 Jan; 25(1):232-248. PubMed ID: 28129117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular interactions between tumor and its microenvironment in malignant gliomas.
    Ellert-Miklaszewska A; Pasierbinska M; Poleszak K; Kamińska B
    Postepy Biochem; 2018 Oct; 64(2):129-140. PubMed ID: 30656895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
    Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
    Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglia-glioma cross-talk: a two way approach to new strategies against glioma.
    Arcuri C; Fioretti B; Bianchi R; Mecca C; Tubaro C; Beccari T; Franciolini F; Giambanco I; Donato R
    Front Biosci (Landmark Ed); 2017 Jan; 22(2):268-309. PubMed ID: 27814616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies.
    da Fonseca AC; Badie B
    Clin Dev Immunol; 2013; 2013():264124. PubMed ID: 23864876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.
    Zeiner PS; Preusse C; Golebiewska A; Zinke J; Iriondo A; Muller A; Kaoma T; Filipski K; Müller-Eschner M; Bernatz S; Blank AE; Baumgarten P; Ilina E; Grote A; Hansmann ML; Verhoff MA; Franz K; Feuerhake F; Steinbach JP; Wischhusen J; Stenzel W; Niclou SP; Harter PN; Mittelbronn M
    Brain Pathol; 2019 Jul; 29(4):513-529. PubMed ID: 30506802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.